Hoth Therapeutics Earning Date (HOTH)

USA |NASDAQ |USD

HOTH Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Mar 16, 2022 (est) Dec 31, 2021 - $-0.14 $-0.04
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Mar 16, 2022 (est) Dec 31, 2021 - $0.00 $0.00

Hoth Therapeutics's next estimated earnings date (based on same quarter last year's date) is Mar 16, 2022 for the fiscal quarter ending Dec 31, 2021.

HOTH Earnings Date & History Chart

HOTH Earnings & Revenue Forecast

HOTH Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 3 $-0.57 $-0.61 $-0.55

HOTH Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-0.57 $-0.60 $-0.60

HOTH Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 2 $0.00 $0.00 $0.00

HOTH Earnings Date & Revenue History

HOTH Earnings History

|
Show More
Show More

HOTH Revenue History

|
Show More
Show More

Hoth Therapeutics Next Earnings Date & Report

HOTH Nov 2021 (FQ) Earnings Date & Report Preview

HOTH's next estimated earnings date (based on same quarter last year's report date) is Mar 16, 2022 for the fiscal quarter ending Dec 31, 2021.

Hoth Therapeutics Previous Earnings Dates & Reports

HOTH Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Hoth Therapeutics's previous earnings date was Nov 10, 2021 for its fiscal quarter ended Sep 30, 2021.

HOTH's earnings per share (EPS) was $-0.14, missing the consensus analysts forecast of $-0.12 by -16.67%.

The EPS was higher than the previous fiscal quarter (Jun 2021) by 0.00%, and higher than the same period a year before (Sep 2020) by -12.50%.

Revenues were $0.00.

The company reported a net income of $-3.30M.

Free cash flow for the quarter was $-2.79M , compared to $-2.70M last quarter and $-1.53M a year before.

HOTH Previous Earnings Date & Report Recap: Dec 2020 (FY)

Hoth Therapeutics's previous annual earnings date was Mar 16, 2021 for its fiscal year ended Dec 31, 2020.

HOTH's earnings per share (EPS) was $-0.58, beating the consensus analysts forecast of $-0.63 by -7.94% , and higher than the previous year's EPS (Dec 2019) by -29.99%.

Revenues were $0.00.

The company reported a net income of $-7.20M.

Hoth Therapeutics reported a free cash flow of $-6.30M for its fiscal year, compared to $-5.04M a year ago.